| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Fustin |
黃顏木素 |
20725-03-5 |
詳細(xì)
|
| L-Moses |
2079885-05-3 |
2079885-05-3 |
詳細(xì)
|
| JTE-607 |
化合物JTE-607 HCL |
188791-09-5 |
詳細(xì)
|
| HTH-01-091 |
化合物 T24152 |
2000209-42-5 |
詳細(xì)
|
| CM-675 |
CM-675 |
1872466-47-1 |
詳細(xì)
|
| N-Lactoyl-Phenylalanine |
(LACTICACID)-F(REMARK:LACTICACID是L-乳酸) |
183241-73-8 |
詳細(xì)
|
| BTK inhibitor 17 |
BTK抑制劑17 |
1858206-76-4 |
詳細(xì)
|
| CB-5339 |
1-(4-(芐基氨基)-5,6,7,8-四氫吡啶[2,3-D]嘧啶-2-基)-2-甲基-1H-吲哚-4-甲酰胺 |
1863952-15-1 |
詳細(xì)
|
| FCPR03 |
化合物FCPR03 |
1917347-65-9 |
詳細(xì)
|
| Capsiate |
辣椒素酯 |
205687-01-0 |
詳細(xì)
|
| PDGFR Tyrosine Kinase Inhibitor III |
PDGFR酪氨酸激酶抑制劑III |
205254-94-0 |
詳細(xì)
|
| AZ13705339 hemihydrate |
化合物 T26704 |
2016806-57-6 |
詳細(xì)
|
| L-Palmitoylcarnitine chloride |
L-氯化棕櫚酰肉堿 |
18877-64-0 |
詳細(xì)
|
| SMYD3-IN-1 |
SMYD3-IN-1 |
2095160-79-3 |
詳細(xì)
|
| Abeprazan hydrochloride |
DWP14012 hydrochloride |
1902954-87-3 |
詳細(xì)
|
| RORγt Inverse agonist 6 |
RORγt Inverse agonist 6 |
1887161-80-9 |
詳細(xì)
|
| Bocidelpar |
化合物BOCIDELPAR |
2095128-20-2 |
詳細(xì)
|
| SGC-SMARCA-BRDVIII |
化合物SGC-SMARCA-BRDVIII |
1997319-84-2 |
詳細(xì)
|
| GNE-064 |
化合物GNE-064 |
1997321-20-6 |
詳細(xì)
|
| Laninamivir octanoate |
辛酸拉尼米韋 |
203120-46-1 |
詳細(xì)
|
| MS-PPOH |
MS-PPOH |
206052-02-0 |
詳細(xì)
|
| PD166326 |
PD 166326 |
185039-91-2 |
詳細(xì)
|
| SB-273005 |
SB273005 INTEGRIN抑制劑 |
205678-31-5 |
詳細(xì)
|
| GSK8814 |
GSK8814 |
1997369-78-4 |
詳細(xì)
|
| PHGDH-inactive |
PHGDH-inactive |
1914971-16-6 |
詳細(xì)
|
| MP07-66 |
MP07-66 |
1938056-90-6 |
詳細(xì)
|
| Rilmenidine phosphate |
化合物BU 224 HYDROCHLORIDE |
205437-64-5 |
詳細(xì)
|
| Parsaclisib hydrochloride |
PARSACLISIB HYDROCHLORIDE |
1995889-48-9 |
詳細(xì)
|
| (E)-β-Farnesene |
(E)-β-金合歡烯 |
18794-84-8 |
詳細(xì)
|
| EST64454 hydrochloride |
化合物EST64454 |
1950569-11-5 |
詳細(xì)
|
| ComplementfactorD-IN-2 |
2-Azabicyclo[3.1.0]hexane-3-carboxamide, 2-[2-[3-acetyl-5-(2-methyl-5-pyrimidinyl)-1H-indazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-, (1R,3S,5R)- |
1903742-34-6 |
詳細(xì)
|
| YM-53601 |
YM-53601 |
182959-33-7 |
詳細(xì)
|
| Atuliflapon |
AZD5718 |
2041075-86-7 |
詳細(xì)
|
| PPOH |
2-(2-PROPYNYLOXY)-BENZENEHEXANOIC ACID |
206052-01-9 |
詳細(xì)
|
| ASN007 |
ASN007; ASN-007; ASN 007; |
2055597-12-9 |
詳細(xì)
|
| Zabedosertib |
BAY1834845 |
1931994-81-8 |
詳細(xì)
|
| Sebetralstat |
KVD900 |
1933514-13-6 |
詳細(xì)
|
| Melittoside |
美利妥雙甙 |
19467-03-9 |
詳細(xì)
|
| NSC 617145 |
NSC617145 |
203115-63-3 |
詳細(xì)
|
| Balcinrenone |
AZD9977 |
1850385-64-6 |
詳細(xì)
|
| PC786 |
PC786 |
1902114-15-1 |
詳細(xì)
|
| RIP1 kinase inhibitor 1 |
RIP1 KINASE INHIBITOR 1 |
2095515-38-9 |
詳細(xì)
|
| Spiraeoside |
繡線菊甙 |
20229-56-5 |
詳細(xì)
|
| GSK620 |
GSK620 |
2088410-46-0 |
詳細(xì)
|
| Tovinontrine |
TOVINONTRINE |
2062661-53-2 |
詳細(xì)
|
| Cevidoplenib dimesylate |
CEVIDOPLENIB (DIMESYLATE) |
2043659-93-2 |
詳細(xì)
|
| NQTrp |
N-(1,4-Dihydro-1,4-dioxo-2-naphthalenyl)-L-tryptophan |
185351-19-3 |
詳細(xì)
|
| AOH1160 |
AOH1160 |
2089314-57-6 |
詳細(xì)
|
| PI3Kδ-IN-1 |
PI3Kδ-IN-1 |
1911564-39-0 |
詳細(xì)
|
| HCV-IN-31 |
Adenosine, 2-amino-2'-deoxy-2'-fluoro-N,2'-dimethyl-, (2'R)- |
1998705-62-6 |
詳細(xì)
|
| Eliapixant |
依利哌嗪 |
1948229-21-7 |
詳細(xì)
|
| Sisunatovir hydrochloride |
SISUNATOVIR HCL |
1903763-83-6 |
詳細(xì)
|
| Galicaftor |
ABBV-2222 (GLPG2222) |
1918143-53-9 |
詳細(xì)
|
| 2′,7′-Dichlorofluorescein diacetate |
雙氯熒光黃乙酸乙酯 |
2044-85-1 |
詳細(xì)
|
| JAK1-IN-8 |
JAK1-IN-8 |
1973485-18-5 |
詳細(xì)
|
| TRAM-39 |
化合物 T23471 |
197525-99-8 |
詳細(xì)
|
| P-gp inhibitor 1 |
P-GP INHIBITOR 1 |
2050747-49-2 |
詳細(xì)
|
| CFTR corrector 4 |
CFTR corrector 4 |
1918142-34-3 |
詳細(xì)
|
| ALC-0159 |
甲氧基聚乙二醇雙十四烷基乙酰胺 |
1849616-42-7 |
詳細(xì)
|
| NLG802 |
化合物NLG802 |
2071683-99-1 |
詳細(xì)
|
| Imatinib-d |
化合物CT52923 |
205256-55-9 |
詳細(xì)
|
| Teduglutide |
替度魯肽 |
197922-42-2 |
詳細(xì)
|
| PF-04802367 |
PF-04802367 |
1962178-27-3 |
詳細(xì)
|
| JNJ-DGAT2-A |
JNJ DGAT2-A |
1962931-71-0 |
詳細(xì)
|
| SHP394 |
SHP394 |
2055757-40-7 |
詳細(xì)
|
| IPN60090 |
IPN-60090 |
1853164-83-6 |
詳細(xì)
|
| Ensifentrine |
Ensifentrine |
1884461-72-6 |
詳細(xì)
|
| 4-PPBP maleate |
化合物 T22513 |
201216-39-9 |
詳細(xì)
|
| Sangivamycin |
桑霉素 |
18417-89-5 |
詳細(xì)
|
| SU5204 |
su5204 |
186611-11-0 |
詳細(xì)
|
| S18-000003 |
Benzeneacetamide, N-(2,4-difluorophenyl)-4-[[2-[4-(ethylsulfonyl)phenyl]acetyl]amino]-2-fluoro-α,α-dimethyl- |
2068119-11-7 |
詳細(xì)
|
| RL648_81 |
RL648_81 |
1919050-87-5 |
詳細(xì)
|
| Abeprazan |
非蘇拉贊 |
1902954-60-2 |
詳細(xì)
|
| Bemnifosbuvir |
L-Alanine, N-[[P(S),2'R]-2-amino-2'-deoxy-2'-fluoro-N,2'-dimethyl-P-phenyl-5'-adenylyl]-, 1-methylethyl ester |
1998705-64-8 |
詳細(xì)
|
| 4-Methylumbelliferyl β-D-Glucopyranoside |
4-甲基傘形酮酰-Β-D-吡喃葡糖酸苷 |
18997-57-4 |
詳細(xì)
|
| Oritinib |
化合物ORITINIB |
2035089-28-0 |
詳細(xì)
|
| CFTR corrector 8 |
化合物 CFTR CORRECTOR 8 |
1918142-35-4 |
詳細(xì)
|
| Glycine-2- |
甘氨酸-2-13C |
20220-62-6 |
詳細(xì)
|
| HX531 |
HX 531 |
188844-34-0 |
詳細(xì)
|
| MRZ 2-514 |
4-Piperidinol, 1-[2-(4-hydroxyphenoxy)ethyl]-4-[(4-Methylphenyl)Methyl]-,hydrochloride |
193356-17-1 |
詳細(xì)
|
| Methylene blue hydrate |
L-精氨酸-13C6 鹽酸鹽 |
201740-91-2 |
詳細(xì)
|
| Boc-Asp(OMe)-fluoromethyl ketone |
(3S)-3-[[叔丁氧羰基]氨基]-5-氟-4-氧代-戊酸甲酯 |
187389-53-3 |
詳細(xì)
|
| Vebicorvir |
ABI-H0731 |
2090064-66-5 |
詳細(xì)
|
| ZLD1039 |
3-[ETHYL(TETRAHYDRO-2H-PYRAN-4-YL)AMINO]-N-[(2;3;5;6;7;8-HEXAHYDRO-1-METHYL-3-OXO-4-ISOQUINOLINYL)METHYL]-2-METHYL-5-[6-(4-METHYL-1-PIPERAZINYL)-3-PYRIDINYL]-BENZAMIDE |
1826865-46-6 |
詳細(xì)
|
| USP30 inhibitor 11 |
(S)-1-cyano-N-(4-(6-cyano-5-methoxypyridin-2-yl)thiazol-2-yl)-N-methylpyrrolidine-2-carboxamide |
2067332-64-1 |
詳細(xì)
|
| GENZ-882706 |
2070864-35-4 |
2070864-35-4 |
詳細(xì)
|
| KIRA-7 |
KIRA-7 |
1937235-76-1 |
詳細(xì)
|
| DS-1205b free base |
化合物DS-1205 |
1855860-24-0 |
詳細(xì)
|
| Coblopasvir dihydrochloride |
化合物COBLOPASVIR DIHYDROCHLORID |
1966138-53-3 |
詳細(xì)
|
| SRI-29329 |
化合物SRI-29329 |
2086809-58-5 |
詳細(xì)
|
| MGL-IN-1 |
化合物 T28165 |
1881244-28-5 |
詳細(xì)
|
| SBP-7455 |
化合物SBP-7455 |
1884222-74-5 |
詳細(xì)
|
| ALX-5407 hydrochloride |
N-[(3R)-3-([1,1'-聯(lián)苯]-4-基氧)-3-(4-氟苯基)丙基]-N-甲基甘氨酸鹽酸鹽 |
200006-08-2 |
詳細(xì)
|
| FLT3-IN-10 |
化合物FLT3-IN-10 |
2088735-51-5 |
詳細(xì)
|
| PHD-1-IN-1 |
化合物PHD-1-IN-1 |
2009343-14-8 |
詳細(xì)
|
| Eciruciclib |
化合物 ECIRUCICLIB |
1868086-40-1 |
詳細(xì)
|
| Ro 3-1314 |
9,12-OCTADECADIYNOIC ACID |
2012-14-8 |
詳細(xì)
|
| Befotertinib |
BEFOTERTINIB |
1835667-63-4 |
詳細(xì)
|
| Cedirogant |
4-Piperidineacetic acid, 1-[2,4-dichloro-3-[[7-chloro-5-(trifluoromethyl)-1H-indol-1-yl]methyl]benzoyl]- |
2055496-11-0 |
詳細(xì)
|
| SU4984 |
CIVENTICHEM CV-409 |
186610-89-9 |
詳細(xì)
|